1007-3418
2008 Issue 5
..............page:325,390
..............page:插1
..............page:334,351,362,371,374,386
HBx protein and its down-streaming molecules in hepatocellular carcinomas
ZHAO Xiu-lan;LIU Yi-xin;QIE Shuo;NI Chun-sheng;WANG Dong;WANG Xing-hui;GU Qiang;SUN Bao-cun
ZHAO Xiu-lan;LIU Yi-xin;QIE Shuo;NI Chun-sheng;WANG Dong;WANG Xing-hui;GU Qiang;SUN Bao-cun
..............page:399-400
Relationship of the transforming growth factar beta 3/beta 1 mRNA ratio and collagen Ⅰ synthesis in rat hepatic stellate cells
LI Qi;ZHOU Xia;YU Jiao;QIAN Wei;XU Ke-shu
LI Qi;ZHOU Xia;YU Jiao;QIAN Wei;XU Ke-shu
..............page:397-398
Preventive and treatment effects of granulocyte colony stimulating factor on CCl4 induced chronic liver injury in mice
WANG Jun-ping;SUN Dian-xing;LI Bing-shun;KANG Fu-biao;GUO Zhen-grong;LI Min-ran;KANG Ji-wen;LI Wei-yong
WANG Jun-ping;SUN Dian-xing;LI Bing-shun;KANG Fu-biao;GUO Zhen-grong;LI Min-ran;KANG Ji-wen;LI Wei-yong
..............page:395-396
The radiosensitization effect of cyclooxygenase-2 selective inhibitor NS-398 on HepG2 cells and its mechanism
ZHU Xin-li;HU Li-kuan;WANG Zhen-bo;SONG Yi-peng;ZHANG Shuai;XU Man
ZHU Xin-li;HU Li-kuan;WANG Zhen-bo;SONG Yi-peng;ZHANG Shuai;XU Man
..............page:393-394
The effect of exogenous PEG10 on mitochondrial membrane potential of L02 human liver cells and its possible mechanisms
LIAO Jia-zhi;ZHANG Qiong;TIAN De-an;QIN Hua;WU Xiao-Li;LIN Ju-sheng
LIAO Jia-zhi;ZHANG Qiong;TIAN De-an;QIN Hua;WU Xiao-Li;LIN Ju-sheng
..............page:391-392
Clinical analysis of liver transplantation in elderly patients
LIU Wei;FU Hong;GUO Wen-yuan;MA Jun;FU Zhi-ren;DING Guo-shan
LIU Wei;FU Hong;GUO Wen-yuan;MA Jun;FU Zhi-ren;DING Guo-shan
..............page:389-390
Transforming growth factor beta 1 stimulates the expression of plasminogen activator inhibitor 1 in hepatic stellate cells
ZHU Ying-wei;LIN Yong;ZHANG Xin;WANG Yao-jun;XIE Wei-fen
ZHU Ying-wei;LIN Yong;ZHANG Xin;WANG Yao-jun;XIE Wei-fen
..............page:387-388
Effects of farnesoid X receptor ligand on the metabolism of bile acids in rats with estrogen-induced intrahepatic cholestasis of pregnancy
ZOU Shu-li;LIU Jian;LAN Yi;CHENG Hao;GAN Xiao-lin
ZOU Shu-li;LIU Jian;LAN Yi;CHENG Hao;GAN Xiao-lin
..............page:383-386
Role of caveolin-1 down-regulation by iRNA in human hepatocyte proliferation
PEN Gang;LIU Ying;WANG Xiao-min;ZHAO Chun-hui;ZOU Wei
PEN Gang;LIU Ying;WANG Xiao-min;ZHAO Chun-hui;ZOU Wei
..............page:379-382
Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease
ZHAN Qi;LI Yu-yuan;NIE Yu-qiang;ZHOU Yong-jian;DU Yan-lei;SHA Wei-hong;WANG Hong
ZHAN Qi;LI Yu-yuan;NIE Yu-qiang;ZHOU Yong-jian;DU Yan-lei;SHA Wei-hong;WANG Hong
..............page:375-378
Clinical and pathological features of 16 patients with Gilbert syndrome and 2 cases with genetic analysis
PENG Xiang-xin;WANG Tai-ling
PENG Xiang-xin;WANG Tai-ling
..............page:372-374
Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome
QIU De-kai;LI Xin-min;WEI Jue;YE Li-jing;PENG Yan-shen;MA Xiong
QIU De-kai;LI Xin-min;WEI Jue;YE Li-jing;PENG Yan-shen;MA Xiong
..............page:367-371
Effect of siRNA targeted against survivin on the malignant behaviors of human hepatoma cells
HAN Dan;YE Sheng-long;LIU Bin-bin;CHEN Rong-xin;XUE Tong-chun;SUN Rui-xia;ZHAO Yan;CHEN Jie
HAN Dan;YE Sheng-long;LIU Bin-bin;CHEN Rong-xin;XUE Tong-chun;SUN Rui-xia;ZHAO Yan;CHEN Jie
..............page:363-366
Effects of paclitaxel loaded ultrasound contrast agents on cell cycles and ultrastructural features of HepG2 cells
LIU Yao;KANG Juan;WU Xiao-ling;WANG Zhi-gang;WANG Zhao-xia;LI Pan
LIU Yao;KANG Juan;WU Xiao-ling;WANG Zhi-gang;WANG Zhao-xia;LI Pan
..............page:360-362
Tumor-targeting expression of a new tumor suppressor gene HCCS1 and its tumor-selective inhibitory effects on hepatocellular carcinoma
ZHANG Jian;GAN Yu;HU Jing-ying;ZHAO Xin-tai
ZHANG Jian;GAN Yu;HU Jing-ying;ZHAO Xin-tai
..............page:355-359
The effects of sympathetic neurotransmitters and adrenergic receptors on liver fibrosis in murine schistosomiasis
DUAN Rui-xian;TANG Wang-xian;WU Cui-huan;LIU Hong-yan;GAO Xiao;GUO Yan;CHENG Yong-wei;YANG Yu-zhen
DUAN Rui-xian;TANG Wang-xian;WU Cui-huan;LIU Hong-yan;GAO Xiao;GUO Yan;CHENG Yong-wei;YANG Yu-zhen
..............page:352-354
Adefovir dipivoxil treatment of hepatic cirrhosis complicated with hepatitis B virus associated glomerulonephritis
LI Dong-fu;JIN Zhen-jing;CHEN Yong-sheng;QIAO Lian-ming;ZHOU Jian
LI Dong-fu;JIN Zhen-jing;CHEN Yong-sheng;QIAO Lian-ming;ZHOU Jian
..............page:349-351
An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients
DU Xiao-fei;ZHANG Yong-hong;MA Li-na;YAN Hui-ping;CHEN Xin-yue;WU Hao
DU Xiao-fei;ZHANG Yong-hong;MA Li-na;YAN Hui-ping;CHEN Xin-yue;WU Hao
..............page:345-348
The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HbeAg-positive chronic hepatitis B
XIE Dong-ying;LIN Bing-liang;XU Qi-huan;CHEN You-ming;LU Wei-lun;LI Jian-guo;GAO Zhi-liang
XIE Dong-ying;LIN Bing-liang;XU Qi-huan;CHEN You-ming;LU Wei-lun;LI Jian-guo;GAO Zhi-liang
..............page:341-344
A guideline for the use of nucleoside/tide analogues in treating chronic hepatitis B
Editorial Board of the Chinese Journal of Hepatology
Editorial Board of the Chinese Journal of Hepatology
..............page:335-340
..............page:329-334
..............page:326-328
Chinese roadmap for treating chronic hepatitis B with telbivudine
Chinese Roadmap Expert Group for Telbivudine Treatment
Chinese Roadmap Expert Group for Telbivudine Treatment
..............page:323-325
More research needed on antiviral treatment for chronic hepatitis B
REN Hong;ZHANG Ding-feng
REN Hong;ZHANG Ding-feng
..............page:321-322